Brief: Nordic Nanovector Announces EU Patent Granted Covering The Use Of Alpha37

Thor Medical ASA

30/07/2020 07:05

July 30 (Reuters) - Nordic Nanovector ASA  NORN.OL :
    * NORDIC NANOVECTOR ANNOUNCES EU PATENT GRANTED COVERING THE
USE
OF ALPHA37
    * TO ANNOUNCE GRANT OF AN EU PATENT COVERING USE OF ALPHA37
FOR
TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND
NON-HODGKIN'S LYMPHOMA (NHL)
    * EU PATENT NO. 3272364, WHICH IS ENTITLED "CHIMERIC
THERAPEUTIC
ANTIBODIES" WILL BE ACTIVE UNTIL 2032 WITH OPTION OF PROLONGING
FOR FIVE 5 ADDITIONAL YEARS.

Source text for Eikon:  ID:nObiywm7Va 
Further company coverage:  NORN.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))